Thymic, Antimicrobial & Regulatory Peptides

Thymic, antimicrobial and regulatory research peptides Australia — a reference-standard category grouping several structurally distinct short-peptide and polypeptide chemical classes, each supplied as an HPLC-verified, research-grade analytical reference material for Research Use Only (RUO). It covers the gastric pentadecapeptide BPC-157 (a 15-residue synthetic sequence); thymic-derived polypeptides including beta-thymosin family members (Thymosin Beta-4 and the TB-500 / TB4 fragment) and thymic alpha-1; cationic antimicrobial-class peptides such as LL-37 and the tripeptide KPV; and additional regulatory sequences including VIP and Larazotide. These are neutral chemical-class descriptors only. The common structural basis across the group is a defined linear amino-acid chain, characterised here by primary sequence, molecular mass and chromatographic purity. Every item ships with batch-specific verification: reversed-phase HPLC purity determination, mass-spectrometric identity confirmation and a Batch Verification Report (BVR), backed by Australian domestic supply. No therapeutic, cosmetic or in-vivo application is described or implied.